| J9271 | Injection, pembrolizumab, 1 mg | 6,000 | $40 | $246K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,860 | $40 | $184.7K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,160 | $20 | $26.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $100 | $16.8K |
| Q5116 | Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg | 450 | $20 | $9.3K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 20 | $200 | $3.6K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 60 | $50 | $3.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 30 | $100 | $3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 20 | $140 | $2.8K |
| J9070 | Cyclophosphamide, 100 mg | 170 | $20 | $2.7K |